Surfactant Production Research Articles

Chronic Hypoxia in an EXTrauterine Environment for Neonatal Development Impairs Lung Development.

Severe fetal hypoxia poses a significant risk to lung development resulting in severe postnatal complications. Existing chronic hypoxia animal models lack the ability to achieve pathologically reduced fetal oxygen without compromising animal development, placental blood flow, or maternal health. Using an established model of isolated chronic hypoxia involving the Extrauterine Environment for Neonatal Development (EXTEND), we are able to investigate the direct impact of fetal hypoxia on lung development. Oxygen delivery to preterm fetal lambs (105-110 days GA) delivered by cesarean section was reduced, and animals were supported on EXTEND through the canalicular or saccular stage of lung development. Fetal lambs in hypoxic conditions showed significant growth restriction compared to their normoxic counterparts. We also observed modest aberrant vascular remodeling in the saccular group after hypoxic conditions with decreased macrovessel numbers, microvascular endothelial cell numbers, and increased peripheral vessel muscularization. In addition, fetal hypoxia resulted in enlarged distal airspaces and decreased septal wall volume. Moreover, there was a reduction in mature SFTPB and processed SFTPC protein expression concomitant with a decrease in AT2 cell number. These findings demonstrate that maternally-independent fetal hypoxia predominantly impacts distal airway development, AT2 cell number, and surfactant production with mild effects on the vasculature.

Behavior of Microbubbles on Air-Aqueous Interfaces.

Animal-derived lung surfactants have saved millions of lives of preterm neonates with neonatal Respiratory Distress Syndrome (nRDS). However, a replacement for animal-derived lung surfactants has been sought for decades due to its high manufacturing cost, inaccessibility in low-income countries, and failure to show efficacy when nebulized. This study investigated the use of lipid-coated microbubbles as potential replacements for exogenous lung surfactants. Three different formulations of microbubbles (DPPC with/out PEG40-stearate and poractant alfa) were prepared, and their equilibrium and dynamic surface tensions were tested on a clean air-saline interface or a simulated air-lung fluid interface using a Langmuir-Blodgett trough. In dynamic surface measurements, microbubbles reduced the minimum surface tension compared with the equivalent composition lipid suspension: e.g., PEG-free microbubbles had a minimum surface tension of 4.3 mN/m while the corresponding lipid suspension and poractant alfa had 20.4 (p ≤ 0.0001) and 21.8 mN/m (p ≤ 0.0001), respectively. Two potential mechanisms for the reduction of surface tension were found: Fragmentation of the foams created by microbubble coalescence; and clustering of microbubbles in the aqueous subphase disrupting the interfacial phospholipid monolayer. The predominant mechanism appears to depend on the formulation and/or the environment. The use of microbubbles as a replacement for exogenous lung surfactant products thus shows promise and further work is needed to evaluate efficacy in vivo.

Betamethasone improved near-term neonatal lamb lung maturation in experimental maternal asthma.

Maternal asthma is associated with increased rates of neonatal lung disease, and fetuses from asthmatic ewes have fewer surfactant-producing cells and lower surfactant-protein B gene (SFTPB) expression than controls. Antenatal betamethasone increases lung surfactant production in preterm babies, and we therefore tested this therapy in experimental maternal asthma. Ewes were sensitised to house dust mite allergen, and an asthmatic phenotype induced by fortnightly allergen lung challenges; controls received saline. Pregnant asthmatic ewes were randomised to receive antenatal saline (asthma) or 12mg intramuscular betamethasone (asthma+beta) at 138 and 139 days of gestation (term=150 days). Lambs were delivered by Caesarean section at 140 days of gestation and ventilated for 45min before tissue collection. Lung function and structure were similar in control lambs (n=16, 11 ewes) and lambs from asthma ewes (n=14, 9 ewes). Dynamic lung compliance was higher in lambs from asthma+beta ewes (n=12, 8 ewes) compared to those from controls (P=0.003) or asthma ewes (P=0.008). Lung expression of surfactant protein genes SFTPA (P=0.048) and SFTPB (P<0.001), but not SFTPC (P=0.177) or SFTPD (P=0.285), was higher in lambs from asthma+beta than those from asthma ewes. Female lambs had higher tidal volume (P=0.007), dynamic lung compliance (P<0.001), and SFTPA (P=0.037) and SFTPB gene expression (P=0.030) than males. These data suggest that betamethasone stimulates lung maturation and function of near-term neonates, even in the absence of impairment by maternal asthma.

Toxicity and environmental aspects of surfactants

Abstract As the single largest class of specialty chemicals, surfactants are consumed in huge quantities in our daily life and in many industrial areas. In the past, the attention was focused entirely on technical performance. However, starting from the 1970s and 80s, surfactant related environmental concerns have become the main driving force to upgrade surfactant production technology to make more benign or “greener” products. For this reason, environmental issues, dermatological effects, and oral toxicity are the main priorities when surfactants are considered for a specific purpose. In this paper, we present five cases to demonstrate how the surfactant industry tackles these challenges to mitigate the environmental and health effects associated with surfactant consumption. We also discuss the important role played by surfactants in a current carbon capture and storage (CCS) strategy to reduce the CO2 level in the atmosphere. Surfactant-based stable CO2 foam flooding is a well-established enhanced oil recovery technique. It has been considered to be an economically realistic procedure to sequester large amounts of CO2 in geological formations.

Fully Atom-Efficient Solvent-Mediated Biopolymer Manufacturing: A Base Case Illustrated with Macromolecular Surfactants Tailored to Stable Polymer-Water Interfaces.

This work introduces a novel 1-pot, 0-waste, 0-VOC methodology for synthesizing polymeric surfactants using acrylated epoxidized soybean oil and acrylated glycerol as primary monomers. These macromolecular surfactants are synthesized via reversible addition-fragmentation chain transfer (RAFT) polymerization, allowing for tunable hydrophilic-lipophilic balance (HLB) and ionic properties. We characterize the copolymers' chemical composition and surface-active properties, and evaluate their effectiveness in forming and stabilizing emulsions of semiepoxidized soybean oil and poly(acrylated epoxidized high oleic soybean oil). Comprehensive analyses, including gel permeation chromatography, nuclear magnetic resonance spectroscopy, dynamic light scattering, particle size distribution, zeta potential, and critical micelle concentration, provide detailed insights into the copolymers and the emulsions they form. The results demonstrate that the RAFT-polymerized surfactants offer long-lasting stability and effectively disperse both common oil-in-water emulsions and highly viscous and hydrophobic polymer latexes. These surfactants outperform traditional small molecule surfactants by reducing particle size and preventing phase separation, even over extended storage periods. Stable polymer-water interfaces are achieved through HLB control, tailored by monomer composition, and the final product requires no additional purification since polymerization occurs in liquid surfactants. While small molecules contribute to rapid micelle formation, the polymeric components enhance long-term stability through steric repulsion and slower dynamics. This method enables even the emulsification of polymers with submicron particle size, which ordinarily requires emulsion polymerization. Integrating biobased polymeric surfactants with advanced polymer processing techniques opens new possibilities for transforming highly hydrophobic polymers into latexes, facilitating downstream applications. This innovation enhances the environmental sustainability of surfactant production and broadens the potential for polymer emulsification technologies. Additionally, the integrated solution-processing approach demonstrated here can be applied to other emerging polymers, where judiciously selected nonvolatile solvents facilitate the polymerization and play a role in the final application.

Effects of surface tension and contact angle on pore structure development of coal samples under chemical solution erosion

To explore the influence of surfactant concentration on the pore structure and permeability of coal samples during the chemical enhancement of coalbed methane production, different kinds and different concentrations of surfactants were added to the chemical solution, and the coal samples were soaked. Methods such as low-field nuclear magnetic resonance testing (NMR), fractal theory, permeability testing, surface tension testing, and contact angle testing were employed to analyze the variation patterns of coal sample pore structure, fractal characteristics, and permeability, and to explore the correlation between surface tension, contact angle, and the degree of pore structure development. The results show that the increase in total porosity of coal samples, the increase in the seepage pore porosity, the decrease in Dt, and the growth rate of permeability increase with the increase in surfactant concentration, and are negatively correlated with the surface tension of the solution and the contact angle of the coal-solution interface, while the decrease in Ds is not significantly correlated with surfactant concentration, surface tension, or contact angle. In terms of the erosion effect of a chemical solution on coal samples, the influence of contact angle is greater than that of surface tension, while surface tension has the greatest impact on the development of adsorption pores. By adding different surfactants, the surface tension of the chemical solution and the contact angle of the coal-solution interface can be controlled, further promoting the erosion of coal samples, which is of positive significance for the chemical enhancement of coalbed methane production.

Synthesis, Structure, and Actual Applications of Double Metal Cyanide Catalysts.

Double metal cyanide (DMC) complexes represent a unique family of materials with an open framework structure. The main current application of these complexes in chemical industry is their use as catalysts (DMCCs) of the ring-opening polymerization of propylene oxide (PO), yielding branched polyols, highly demanded in production of polyurethanes and surfactants. The actual problem of chemical fixing carbon dioxide from the atmosphere gave new impetus to the development of DMCCs, which turned out to be effective in oxirane/CO2 copolymerization. In recent years, new types and formulations of DMCCs were created, so that greater understanding of the reaction mechanisms was achieved and new fields of catalytic applications were found. In the present review, we summarized background and actual information about the synthesis, structure, and mechanisms of the action of DMCCs, as well as their application in the development of new materials and fine chemicals.

Enhancement of mono-acylated MEL-D production in an acyltransferase gene-deleted strain of Pseudozyma tsukubaensis by supplementation with di-acylated MEL-B in culture medium

Mannosylerythritol lipids (MELs) are glycolipid biosurfactants produced by various yeasts. MEL producers produce mainly di-acylated MELs (consisting of two fatty acid chains). Among them, Pseudozyma tsukubaensis is a di-acylated MEL-B (d-MEL-B) producer. In a previous study, we generated an acyltransferase-deleted strain of P. tsukubaensis (ΔPtMAC2), which selectively produced mono-acylated MEL-D (m-MEL-D, consisting of one fatty acid chain), but not d-MEL-B. However, m-MEL-D productivity in ΔPtMAC2 was low, and oil consumption was significantly reduced compared to the parent strain. Based on these findings, we hypothesized that the d-MEL-B produced by the parent strain may act as an emulsifier in the culture medium, leading to easier utilization of the oil. By contrast, the m-MEL-D produced by ΔPtMAC2 may not have the ability to emulsify oil, thus the oil is used inefficiently and productivity of m-MEL-D is low. Therefore, we expected that adding d-MEL-B to the culture medium during ΔPtMAC2 cultivation would increase m-MEL-D production. To enhance the oil consumption and m-MEL-D production of ΔPtMAC2, d-MEL-B and chemical surfactants were added to the culture medium as emulsifiers during ΔPtMAC2 cultivation. Adding d-MEL-B enhanced both the oil consumption and m-MEL-D production of ΔPtMAC2; Tween 20 and Triton X-100 also showed enhancement effects. As expected, d-MEL-B, Tween20 and TritonX-100, showed marked olive oil emulsification activity, whereas m-MEL-D did not. These results strongly support our hypothesis and significantly improve m-MEL-D productivity.

From dairy waste to value-added bio-based surfactants

Cheese whey permeate, the main waste stream of dairy industry, was used as a starting material for the production of bio-based surfactants (SFAEs). Specifically, the first step in the sustainable chemoenzymatic synthesis of n-butyl 6-O-palmitoyl-D-glycosides (Fischer glycosylation followed by enzymatic esterification) was optimized by a chemometric study. The surfactancy of the prepared isomeric mixtures was deeply investigated in terms of static and dynamic interfacial tension and emulsifying capability over time.

Transamniotic Delivery of Surfactant Protein B mRNA in a Healthy Model

Introduction: We sought to determine whether exogenous surfactant protein B (SPB) mRNA could be incorporated and translated by the fetal lung after simple transamniotic administration. Methods: Fetuses (n = 149) of twelve time-dated dams underwent intra-amniotic injections of either human SPB (hSPB) mRNA encapsulated into lipopolyplex (mRNA, n = 99) or lipopolyplex without mRNA (control; n = 50) on gestational day 17 (E17, term = E21–22). Lungs were screened for hSPB by enzyme-linked immunosorbent assay daily until term. Phosphatidylcholine (PC) (a surrogate for surfactant production) was measured in the amniotic fluid by fluorometric assay. Statistical analysis included nonparametric Wilcoxon rank sum test. Results: Significantly improved survival in the mRNA group compared to controls was observed at E18 (100% vs. 85.7%) and E20 (100% vs. 83.3%) (both p < 0.001). When controlled by mRNA-free injections, hSPB protein was detected in the mRNA group’s lungs at E18, 19, and term (p = 0.002 to <0.001). Amniotic fluid PC levels were increased compared to control at term [285.9 (251.1, 363.9) μM versus 263.1 (222.8, 309.1) μM]; however, this did not reach significance (p = 0.33). Conclusions: Encapsulated exogenous SPB mRNA can be incorporated and translated by fetal lung cells following intra-amniotic injection in a healthy rat model. Transamniotic mRNA delivery could become a novel strategy for perinatal surfactant protein replacement.

The Effect of Pro- and Eukaryotic Inductors on the Synthesis and Antimicrobial Activity of Acinetobacter calcoaceticus IMV B-7241 Surfactants

By now, the mixed cultivation ("co-cultivation") of antimicrobial compound producers with other microorganisms or the introduction of biological inductors in different physiological states (live and inactivated cells, as well as the corresponding supernatants) into the culture medium is a simple, cheap, and effective way to increase the synthesis of practically important microbial metabolites and regulate their biological activity. In most studies, researchers use bacterial strains of various species as inductors, however, in recent years, there have been an increasing number of publications reporting the use of eukaryotic inductors, in response to which there's observed an increase in the synthesis of antimicrobial compounds by the bacterial producers. In addition, the effectiveness of biological inductors depends on the conditions of their cultivation and physiological state. Aim. To study the effect of the methods of preparation and physiological state of biological inductors (gram-negative bacteria Enterobacter cloacae C-8 and yeast Saccharomyces cerevisiae BTM-1) on the activity of biosynthetic enzymes and antimicrobial activity of Acinetobacter calcoaceticus IMV B-7241 surfactants. Methods. Purified glycerol and crude glycerol in equimolar carbon concentration were used as a substrate for cultivation of A. calcoaceticus IMV B-7241. The microbial inductors were grown on both agar and liquid media with glucose as a carbon source. Live or inactivated cells of S. cerevisiae BTM-1 or E. cloacae C-8, as well as the corresponding supernatant, were added to the medium in an amount of 2.5–10 % (v/v). The extracellular surfactants were obtained from the supernatant of the culture liquid by extraction with a mixture of chloroform and methanol (2:1). The antimicrobial activity of surfactants against bacterial (Bacillus subtilis BT-2, Escherichia coli IEM-1, Staphylococcus aureus BMS-1, Pseudomonas sp. MI-2) and yeast (Candida albicans D-6 and Candida tropicalis PE-2) test cultures was determined by the indicator of the minimum inhibitory concentration. The activity of enzymes for the biosynthesis of surface-active glyco- (phosphoenolpyruvate carboxylase, phosphoenolpyruvate synthetase, phosphoenolpyruvate carboxykinase, trehalose phosphate synthase) and aminolipids (NADP+-dependent glutamate dehydrogenase) was analyzed in cell-free extracts obtained after sonication of cells. Results. The introduction into the culture medium of A. calcoaceticus of IMV B-7241 with glycerol of various purification degrees, both pro- and eukaryotic inductors in different physiological states was accompanied by the synthesis of surfactants, the antimicrobial activity of which against the test cultures was higher by one to two orders of magnitude compared to preparations obtained without inductors. It was found that E. cloacae C-8 cells grown in liquid medium were slightly more effective as inductors than those grown in agar medium: the minimum inhibitory concentrations against bacterial and yeast cultures of surfactants synthesised in their presence were 1–6 and 2.5–8 μg/mL, respectively. When live S. cerevisiae BTM-1 or E. cloacae C-8 cells were used as inductors, the production of microbial surfactants with higher antimicrobial activity than those synthesized in the presence of inactivated cells or supernatants was observed: the minimum inhibitory concentrations against the test cultures were in the range of 0.85–16, 2–20 and 1.5–22 μg/mL, respectively. The higher antimicrobial activity of surfactants synthesized in the presence of a pro- or eukaryotic inductor in the medium with purified glycerol may be caused by an increase of aminolipids in their composition, as evidenced by a 1.6–2.1-fold increase in NADP+-dependent glutamate dehydrogenase activity in A. calcoaceticus IMV B-7241 cells compared to the values of cultivation without inductors. The same level of activity of this enzyme during the cultivation of the IMV B-7241 strain in the medium with crude glycerol in the presence of inductors and without them may indicate the synthesis under such conditions of other, than aminolipids, metabolites with antimicrobial activity. Conclusions. As a result of this study, it was established that the antimicrobial activity of A. calcoaceticus IMV B-7241 surfactants can be increased by introducing pro- and eukaryotic inductors in the form of live or inactivated cells, as well as the corresponding supernatants into the medium with glycerol of different degrees of purification.

The Potential of Ambroxol as a Panacea for Neonatal Diseases: A Scoping Review.

Ambroxol, a commonly used mucolytic agent, has been extensively studied for its clinical effectiveness in managing respiratory conditions in pediatric and adult patients. The existing body of research on ambroxol demonstrates its safety and efficacy. However, its potential role in preventing and treating neonatal diseases still needs to be explored. This scoping review aims to shed light on the unexplored potential of ambroxol, particularly its applications in perinatal and neonatal care. We aim to offer valuable insights for healthcare professionals, researchers, and academics, thus presenting a positive perspective. Key scientific databases such as Google Scholar, PubMed, Cochrane Library, and Europe PMC were meticulously searched for relevant literature on ambroxol in perinatal and neonatal medicine. Gray literature was also surveyed, and the search encompassed all study designs and languages up to June 2024. Furthermore, citations and reference lists of relevant articles were scrutinized to identify additional pertinent literature. Ambroxol has demonstrated promising effects in preventing and managing respiratory distress syndrome (RDS). It can enter the placental circulation and rapidly build up in human lung tissue to a much greater extent than in plasma. It promotes fetal lung maturation, surfactant production, and alveolar expansion. Numerous studies have demonstrated the efficacy of antenatal and postnatal ambroxol in the prevention and treatment of RDS. Ambroxol has the potential to be administered intravenously or through nebulization, offering the hopeful possibility of reducing the high failure rate typically associated with non-invasive ventilation in extremely preterm infants, instilling a sense of hope and optimism about the potential of ambroxol. It also shows potential in treating bronchopulmonary dysplasia, meconium aspiration syndrome, and neonatal infections. Ambroxol has been observed to assist in the closure of patent ductus arteriosus in preterm infants by inhibiting vasodilator agents such as nitric oxide and exerting vasoconstrictive properties. However, these biological actions may raise concerns regarding the potential induction of pulmonary hypertension and an increased risk of necrotizing enterocolitis. The present scoping review also examines the clinical evidence and the potential of ambroxol in reducing the incidence of intraventricular hemorrhage in preterm infants. Ambroxol may have potential analgesic properties in managing neonatal pain, and as it can penetrate the blood-brain barrier, it suggests potential neuroprotective properties. These properties may encompass the modulation of microglial activation and the antagonistic impact on glutamate receptors. Ambroxol's attributes could contribute to a decreased susceptibility to neurological complications and have demonstrated anticonvulsant effects in preclinical studies. While low-to-moderate-quality evidence indicates potential applications of ambroxol in neonatal care, further research is needed to determine the drug's optimal dosing, timing, and safety profiles in this patient population. We need to investigate ambroxol's potential synergistic effects with antenatal steroids. Exploration is required to assess ambroxol's potential in reducing the high failure rate associated with non-invasive respiratory support for RDS. Lastly, comprehensive studies on the long-term neurodevelopmental outcomes of neonates exposed to ambroxol are essential.

Microorganisms usage in enhanced oil recovery: Mechanisms, applications, benefits, and limitations

AbstractIn today's world, where the oil and gas industry faces challenges such as declining production and the increasing need for efficient resource utilization, microbial enhanced oil recovery (MEOR) is introduced as a biological solution. This method, based on mechanisms like surfactant production, reduction of oil viscosity, and improvement of reservoir chemical properties, can increase oil recovery by 15%–20%, reduce operational costs by up to 30%, and is highly environmentally friendly. This study reviews various MEOR methods, including stimulating existing microbial activity in reservoirs or injecting microbes and nutrients. It presents successful examples of this technology in different oil fields, showing how MEOR can be a sustainable alternative to traditional methods. However, challenges such as the need for further research, control of biological processes, and advanced technology usage are also emphasized.

Carbon nitride nanosheets induce pulmonary surfactant deposition via dysfunction of alveolar secretion and clearance

Graphitic carbon nitride is a new type of carbon-based nanomaterial with superior properties and great potential for application, which raised great concerns about their environmental and occupational exposure. Graphitic carbon nitride has been reported to accumulate in the lung potentially, however, the respiratory hazard effect of graphitic carbon nitride is still unknown. In the present study, we reported that graphitic carbon nitride (g-CN) and its doped variant sulfur doped graphitic carbon nitride (S-g-CN) nanosheets inhalation induced pulmonary inflammation, increased the production of pulmonary surfactant in alveolar type II epithelial cells, accompanied by the upregulation of lipids transporter expression levels in alveolar macrophages to clear excessive pulmonary surfactant in the alveolar. Further investigation found that the internalization of g-CN and S-g-CN prevented lipid phagocytosis and metabolic processes in alveolar macrophages, ultimately leading to the deposition of proteins and phospholipids in the lung. Furthermore, we found that g-CN was more robust in inhalation toxicity compared to sulfur doped form, which meant the doping of sulfur in graphitic carbon nitride reduced hazardous effects on the respiratory system. In summary, our study demonstrated that inhalation of graphitic carbon nitride nanosheets caused the deposition of pulmonary surfactants in lung, providing an insightful reference for pulmonary toxicity assessment of graphitic carbon nitride.

Synthesis of melanin-like amino acid surfactant with enzymatic hydrolysates from silk degumming water

The degummed wastewater from silk processing contains a huge amount of amino acids and polypeptides from sericin. The silk degumming water is far from being exploited fully. Sericin in the degumming water is generally wasted and causes environmental pollution. In this study, simulated silk degumming water was hydrolyzed by alkaline protease to produce abundant amino acids and polypeptides. After enzymatic hydrolysis, the maximum free amino groups concentration in the silk degumming water was approximately 54 mM. It facilitated the recycling of silk degumming water for the production of melanin-like amino acid surfactants as raw materials. 4-Tert-butylcatechol was used as the starting material to generate o-quinone via oxidation by ceric ammonium nitrate. o-Quinone was coupled with free amino groups in enzymatic hydrolysates of silk degumming water to synthesize a sericin-based amino acid surfactant as hydrophobic and hydrophilic group, respectively. Through the green and simple synthesis route, the product was characterized to have a novel melanin-like structure. The product exhibited superior surface-active properties by lowering the surface tension to 32.39 mN m−1. Furthermore, it demonstrated good foaming ability and foam stability, with the initial foam volume of 37 mL and the foam half-life time of more than 25 min. The product owned a good emulsification ability in the oil-water emulsion with delamination time of 297 s and 291 s for emulsion formed by soybean oil and liquid paraffin, respectively. The wetting time of the canvas sheet was only 134 s. Consequently, the product showed low surface tension, good foaming, emulsifying, and wetting properties.

Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: In Vitro Testing and Characterization

PurposeImproving the deep lung delivery of aerosol surfactant therapy (AST) with a dry powder formulation may enable significant reductions in dose while providing improved efficacy. The objective of Part I of this two-part study was to present the development of a new dry powder aerosol synthetic lung surfactant (SLS) product and to characterize performance based on aerosol formation and realistic in vitro airway testing leading to aerosol delivery recommendations for subsequent in vivo animal model experiments.MethodsA new micrometer-sized SLS excipient enhanced growth (EEG) dry powder formulation was produced via spray drying and aerosolized using a positive-pressure air-jet dry powder inhaler (DPI) intended for aerosol delivery directly to intubated infants with respiratory distress syndrome (RDS) or infant-size test animals.ResultsThe best-case design (D2) of the air-jet DPI was capable of high emitted dose (> 80% of loaded) and formed a < 2 µm mass median aerodynamic diameter (MMAD) aerosol, but was limited to ≤ 20 mg mass loadings. Testing with a realistic in vitro rabbit model indicated that over half of the loaded dose could penetrate into the lower lung regions. Using the characterization data, a dose delivery protocol was designed in which a 60 mg total loaded dose would be administered and deliver an approximate lung dose of 14.7–17.7 mg phospholipids/kg with a total aerosol delivery period < 5 min.ConclusionsA high-efficiency aerosol SLS product was designed and tested that may enable an order of magnitude reduction in administered phospholipid dose, and provide rapid aerosol administration to infants with RDS.

Lepidosiren paradoxa, study with light and electron microscopy of the lung

In this study, we describe the pulmonary morphology of the South American lungfish (Lepidosiren paradoxa) using optical and electron microscopy. We observed cells similar to mammalian type I pneumocytes and mammalian-type II pneumocytes, which may be associated with surfactant production

Increasing 1,4-Diaminobutane Production in Escherichia coli by Optimization of Cofactor PLP and NADPH Synthesis.

1,4-diaminobutane is widely used in the industrial production of polymers, pharmaceuticals, agrochemicals and surfactants. Owing to economic and environmental concerns, there has been a growing interest in using microbes to produce 1,4-diaminobutane. However, there is lack of research on the influence of cofactors pyridoxal phosphate (PLP) and NADPH on the synthesis of 1,4-diaminobutane. PLP serves as a cofactor of ornithine decarboxylase in the synthesis of 1,4-diaminobutane. Additionally, the synthesis of 1 mol 1,4-diaminobutane requires 2 mol NADPH, thus necessitating consideration of NADPH balance in the efficient synthesis of 1,4-diaminobutane by Escherichia coli. The aim of this study was to enhance the synthesis efficiency of 1,4-diaminobutane through increasing production of PLP and NADPH. By optimizing the expression of the genes associated with synthesis of PLP and NADPH in E. coli, cellular PLP and NADPH levels increased, and the yield of 1,4-diaminobutane also increased accordingly. Ultimately, using glucose as the primary carbon source, the yield of 1,4-diaminobutane in the recombinant strain NAP19 reached 272 mg/L·DCW, by increased 79% compared with its chassis strain.

Impact of anionic surfactant-based foaming agents on the properties of lightweight foamed concrete

Due to its low density, high thermal insulation, and ability to contribute to energy saving, lightweight foamed concrete (LWFC) is a versatile material that finds use in a wide variety of contexts. The properties of foam are significantly influenced by the selection of surfactant and foam production parameters, which in turn impact the properties of LWFC. Therefore, the anionic foaming agent effect on the distinct properties of LWFC needs to be investigated to create a lightweight structure in modern days. This research aims to better understand the interactions between cement particles and anionic foaming agents, which produce stable and consistent aqueous foams because of their negative charge. Investigations were carried out on the effects of anionic foaming agents of LWFC features on the fresh state characteristics, mechanical behaviour, microstructure, and transport properties. In this investigation, four distinct types of anionic surfactants specifically sodium lauryl sulphate (SLS), alpha olefin sulfonate (AOS), sodium lauryl ether sulphate (SLES), and sodium alcohol ether sulphate (AES) were considered, with all mixes maintaining a consistent cement-to-sand ratio and identical amounts of foaming agents. The fresh state testing exhibits that AOS-based LWFC may be preferred when lower setting time and spreadability, as well as a higher density, are required. The AOS-based LWFC exhibits lower capillary sorption, water absorption, and gas permeability than SLES, SLS, and AES-based LWFC. At 28 days, about 91–96 % of the compressive, tensile, and flexural strength of AOS-based LWFC is obtained for SLS, SLES, and AES-based LWFC. In addition, at the same curing age, the results for modulus of elasticity were over 6 % higher in the AOS-based LWFC mixture than in the other mixes. The pore structural and microstructural behavior revealed that AOS and SLS foamed-based LWFC exhibit a considerable reduction of macropores, or long capillaries, with diameters less than 500 µm, which can be used in the lightweight structure in modern days. This research emphasizes the significance of selecting the appropriate foaming agents to optimize the mechanical and transport properties of LWFC, which provides substantial benefits for contemporary construction practices.

Brucella pituitosastrain BU72, a new hydrocarbonoclastic bacterium through exopolysaccharide-based surfactant production.

Hydrocarbon and heavy metal pollution are amongst the most severe and prevalent environmental problems due to their toxicity and persistence. Bioremediation using microorganisms is considered one of the most effective ways to treat polluted sites. In the present study, we unveil the bioremediation potential of Brucella pituitosa strain BU72. Besides its ability to grow on multiple hydrocarbons as the sole carbon source and highly tolerant to several heavy metals, BU72 produces different exopolysaccharide-based surfactants (EBS) when grown with glucose or with crude oil as sole carbon source. These EBS demonstrated particular and specific functional groups as determined by Fourier transform infrared (FTIR) spectral analysis that showed a strong absorption peak at 3250 cm-1 generated by the -OH group for both EBS. The FTIR spectra of the produced EBS revealed major differences in functional groups and protein content. To better understand the EBS production coupled with the degradation of hydrocarbons and heavy metal resistance, the genome of strain BU72 was sequenced. Annotation of the genome revealed multiple genes putatively involved in EBS production pathways coupled with resistance to heavy metals genes such as arsenic tolerance and cobalt-zinc-cadmium resistance. The genome sequence analysis showed the potential of BU72 to synthesise secondary metabolites and the presence of genes involved in plant growth promotion. Here, we describe the physiological, metabolic, and genomic characteristics of Brucella pituitosa strain BU72, indicating its potential as a bioremediation agent.